CoChat

Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission

Open access
· 1997 · American Journal of Psychiatry
Cited by 75

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Demonstration of antidepressant efficacy beyond 6 months has infrequently been addressed, and no long-term efficacy data exist for patients with chronic atypical depression. METHOD: Sixty patients with atypical depression (according to Columbia University criteria) of at least 2 years' duration and who had improved with imipramine or phenelzine were stabilized for 6 months and then randomly continued the same medication or placebo for 6 months. RESULTS: Several baseline differences suggested that patients who entered the discontinuation trial on a regimen of phenelzine were more chronically depressed than the imipramine-treated patients. Survival analysis showed a marked advantage for phenelzine relative to placebo. In addition, patients switched to placebo from phenelzine experienced a recurrence of depressive symptoms significantly more often than patients switched to placebo from imipramine. Patients maintained with imipramine did not have lower relapse rates than those switched from imipramine to placebo. Recurrence rates were 23% for patients maintained on a regimen of phenelzine, 41% for those maintained on a regimen of imipramine, 47% for those switched from imipramine to placebo, and 87% for placebo-treated patients originally treated with phenelzine. CONCLUSIONS: Patients with chronic atypical depression are at high risk of recurrence if phenelzine is withdrawn 6 months after initial improvement. Similar findings were not demonstrated for imipramine; this replicates acute trials demonstrating imipramine's relative ineffectiveness in patients with atypical depression. Differences in recurrence rates after the switch to placebo from phenelzine and imipramine could be due to the two drugs' different mechanisms of action or to baseline differences in the two populations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/ajp.154.1.31

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 21

  1. 10.1001/archpsyc.1976.01770120083009 · DOI · Paper page
  2. 10.1001/archpsyc.1989.01810010091014 · DOI · Paper page
  3. Montgomery SA, 1992, Long-Term Treatment of Depression, 53
  4. 10.3928/0048-5713-19940601-07 · DOI · Paper page
  5. 10.1192/bjp.133.1.28 · DOI · Paper page
  6. 10.1001/archpsyc.1990.01810240013002 · DOI · Paper page
  7. 10.1001/archpsyc.1989.01810090025004 · DOI · Paper page
  8. 10.1017/S0033291700003068 · DOI · Paper page
  9. 10.1016/S0193-953X(18)30161-8 · DOI · Paper page
  10. Robinson DS, 1991, Psychopharmacol Bull, 27, 31
  11. Harrison W, 1986, J Clin Psychiatry, 47, 346
  12. 10.1001/jama.1989.03430070055030 · DOI · Paper page
  13. 10.1001/archpsyc.1988.01800260037004 · DOI · Paper page
  14. 10.1001/archpsyc.1990.01810220051006 · DOI · Paper page
  15. 10.1176/ajp.145.10.1322-b · DOI
  16. McGlashan, 1973, Md
  17. Spitzer RL, 1985, Gibbon M: Structured Clinical Interview for DSM-III-R (SCID)
  18. 10.1136/jnnp.23.1.56 · DOI · Paper page
  19. Derogatis LR, 1977, I, for the Revised Version.
  20. 10.1001/archpsyc.1989.01810120022005 · DOI · Paper page
  21. Agosti V, 1988, J Clin Psychiatry, 49, 196

Cited by

See all 75

Metadata

Venue
American Journal of Psychiatry
Published
1997-01-01
Volume
154
Issue
1
Pages
31-36
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2306187169
Cited by
75
References
6
FWCI
5.31
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.